proline has been researched along with Diabetes Mellitus, Type 2 in 109 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.92) | 18.7374 |
| 1990's | 8 (7.34) | 18.2507 |
| 2000's | 58 (53.21) | 29.6817 |
| 2010's | 18 (16.51) | 24.3611 |
| 2020's | 24 (22.02) | 2.80 |
| Authors | Studies |
|---|---|
| Doumas, M; Karagiannis, A; Kassimis, G; Papadopoulos, C; Patoulias, D | 1 |
| Abd-Elhamied, MA; Abdelhaleem, IA; Kenawy, S; Morsi, AE | 1 |
| Baek, S; Branch, KRH; Del Prato, S; Gerstein, HC; Khurmi, NS; Lam, CSP; Lopes, RD; Niemoeller, E; Pratley, R; Ramasundarahettige, C; Rosenstock, J; Sattar, N | 1 |
| Baynat, L; Borderie, G; Schnebelen, M | 1 |
| Bakker, SJL; Groothof, D; Vogelpohl, FA | 1 |
| He, L; Zhang, H | 1 |
| Gerstein, HC; Khurmi, NS | 1 |
| Chen, F; Liao, J; Lu, Q; Niu, C; Wang, H; Wang, S; Yu, Y | 1 |
| Baek, S; Choi, J; Frias, JP; Muehlen-Bartmer, I; Niemoeller, E; Popescu, L; Rosenstock, J | 1 |
| Abd El-Aty, AM; Cho, W; Hacimuftuoglu, A; Jeong, JH; Jung, TW; Kim, H; Lee, HJ; Oh, H; Park, SY | 1 |
| Bakker, SJL; Groothof, D; Post, A | 1 |
| Bi, Y; Chen, G; Chen, L; Chen, Y; Dai, M; Deng, H; Du, R; Gao, Z; Hu, C; Hu, R; Huo, Y; Lai, S; Li, D; Li, M; Li, Q; Lin, H; Liu, C; Liu, R; Lu, J; Luo, Z; Mu, Y; Ning, G; Qin, G; Qin, Y; Shen, F; Shi, L; Su, Q; Tang, X; Wan, Q; Wang, G; Wang, J; Wang, S; Wang, T; Wang, W; Wang, X; Wang, Y; Wu, S; Xu, G; Xu, M; Xu, Y; Yan, L; Yang, T; Ye, Z; Yu, X; Zhang, D; Zhang, Y; Zhao, J; Zhao, X; Zhao, Z; Zheng, R | 1 |
| Gu, Y; Qiang, W; Sun, Y; Wu, R; Yin, T; Yuan, J | 1 |
| Jia, Y; Jiang, T; Li, S; Ren, Z; Wang, J; Wang, L; Wang, Z; Yu, Y | 1 |
| Das, A; Ghosh, R; Ghosh, S | 1 |
| Cai, G; Cui, A; Fang, J; Fang, X; Fu, W; Gao, C; Hu, Z; Huo, S; Li, H; Li, W; Li, Y; Lin, X; Liu, Y; Liu, Z; Ma, F; Su, W; Sun, X; Wei, S; Wen, J; Xu, Y; Xue, Y; Yan, X; Zhang, H; Zhao, J | 1 |
| Del Prato, S; Derwahl, M; Kang, J; Sorli, CH; Soto, A; Stewart, J; Trautmann, ME; Yoon, KH | 1 |
| Hompesch, M; Kang, J; Kwon, SC; Sorli, CH; Stewart, J; Trautmann, ME; Yoon, KH | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Hu, X; Inam, M; Liu, L; Phan, CU; Shen, J; Tang, G; Wang, JW; Yu, KX; Zhang, WH | 1 |
| Chen, Y; Dong, X; Fu, C; Jiang, Q; Wang, N; Zhu, J | 1 |
| Han, O; Hompesch, M; Kang, J; Morrow, L; Ogbaa, I; Sorli, CH; Stewart, J; Trautmann, ME | 1 |
| Branch, K; Del Prato, S; Dyal, L; Gerstein, HC; Heenan, L; Khurmi, NS; Lam, CSP; Lopes, RD; Pratley, R; Ramasundarahettige, C; Rosenstock, J; Sattar, N | 1 |
| Cooper, ME; Ma, J | 1 |
| Frigori, RB | 1 |
| Banterla, F; Bossi, A; Chianca, A; Donadelli, R; Galbusera, M; Gastoldi, S; Gherardi, G; Haefliger, C; Iliev, I; Noris, M; Parvanova, A; Remuzzi, G; Ruggenenti, P; Rurali, E; Trevisan, R | 1 |
| Lian, LY; Neocleous, V; Phelan, MM; Phylactou, LA; Shammas, C; Skordis, N | 1 |
| Fang, M; Gao, H; Liu, J; Liu, L; Ouyang, Y; Wang, X | 1 |
| Abdel-Azeez, HA; Azab, MM; El Alawi, SM; Zanaty, MF | 1 |
| Black, MH; Buchanan, TA; Haritunians, T; Lawrence, JM; Takayanagi, M; Taylor, KD; Trigo, E; Wang, N; Watanabe, RM; Wu, J; Xiang, AH | 1 |
| Krishnamoorthy, E; Pichu, S; Sathiyamoorthy, J; Umapathy, D; Viswanathan, V | 1 |
| Alvandi, E; Djalali, M; Eshraghian, MR; Keramatipour, M; Koohdani, F; Mansoori, A; Nasli-Esfahani, E; Shidfar, F; Sotoudeh, G; Toupchian, O | 1 |
| Choi, HW; Koh, WP; Lu, Y; Ong, CN; Pan, A; Subramaniam, T; Wang, Y; Yuan, JM | 1 |
| Ganai, BA; Hameed, I; Kadla, SA; Majid, M; Masood, A | 1 |
| Han, JY; Jee, SH; Kim, M; Lee, JH; Lee, SH | 1 |
| Fukushima, H; Hiratate, A; Kitano, K; Munetomo, E; Saito, H; Saito-Hori, M; Takahashi, M; Takaoka, Y; Yamamoto, K | 1 |
| Dong, CP; He, L; He, M; Li, JN; Wang, Y; Ye, F | 1 |
| Ahanchi, SS; Hrabie, JA; Jiang, Q; Kapadia, MR; Keefer, LK; Kibbe, MR; Martinez, J; Pearce, CG; Saavedra, JE; Tsihlis, ND; Varu, VN | 1 |
| Hofman, A; Jaddoe, VW; Moll, HA; Mook-Kanamori, DO; Steegers, EA; Uitterlinden, AG; van Duijn, CM | 1 |
| Borra, RJ; Hällsten, K; Honka, MJ; Iozzo, P; Kemppainen, J; Knuuti, J; Laakso, M; Lautamäki, R; Nuutila, P; Pihlajamäki, J; Takala, T; Vänttinen, M; Viljanen, AP; Virtanen, KA | 1 |
| Akrami, SM; Amiri, P; Doosti, M; Golmohammadi, T; Heshmat, R; Mirzaei, H; Nakhjavani, M | 1 |
| Bossi, A; De Cosmo, S; Motterlini, N; Pellegrini, F; Prudente, S; Remuzzi, G; Ruggenenti, P; Trevisan, R; Trischitta, V | 1 |
| Burke, W; Crouch, J; Fryer-Edwards, K; Fullerton, SM; Yu, JH | 1 |
| Cseh, K; Jermendy, A; Körner, A; Kovács, M; Madácsy, L | 1 |
| Jaakkola, U; Kakko, T; Kallio, J; Raitakari, OT | 1 |
| Bellacchio, E; Carella, M; Delvecchio, M; Ludovico, O; Mastroianno, S; Palladino, T; Sacco, M; Stallone, R; Trischitta, V; Zelante, L | 1 |
| Chan, JC; Germer, S; Ho, JS; Ma, RC; Martin, M; Ng, MC; So, WY; Tam, CH | 1 |
| Chen, H; Chen, J; Hu, H; Mohan, V; Tang, Y; Venkatesan, R; Wang, J; Zhang, H; Zhu, S | 1 |
| Bachovchin, WW; Connolly, BA; Lai, JH; Li, Y; Liu, Y; Milo, LJ; Poplawski, SE; Sanford, DG; Shu, Y; Sudmeier, JL; Woznica, I; Wu, W; Yu, G; Zhao, P; Zhou, Y | 1 |
| Häring, H; Stumvoll, M | 1 |
| Eriksson, JG; Hämäläinen, H; Ilanne-Parikka, P; Keinänen-Kiukaanniemi, S; Laakso, M; Lindi, VI; Lindström, J; Louheranta, A; Tuomilehto, J; Uusitupa, MI; Valle, TT | 1 |
| Brand, E; Herrmann, SM; Ringel, J; Staessen, JA; Wang, JG | 1 |
| Fernández-Real, JM; Fontova, R; Gallart, L; Gutiérrez, C; Richart, C; Simón, I; Vendrell, I; Vendrell, J | 1 |
| Donath, MY; Halban, PA; Joller-Jemelka, HI; Kaiser, N; Maedler, K; Oberholzer, J; Ris, F; Sergeev, P; Spinas, GA | 1 |
| Castelli, LA; Grusovin, J; Macaulay, SL; Ryan, JM; Stoichevska, V; Ward, CW | 1 |
| Boyle, D; Cumming, A; Doney, A; Fischer, B; Flavell, DM; Frew, D; Montgomery, HE; Morris, A; Palmer, CN; World, M | 1 |
| Erkkilä, A; Laakso, M; Lindi, V; Luoma, J; Niskanen, L; Sivenius, K; Uusitupa, MI; Ylä-Herttuala, S | 1 |
| Blüher, M; Lübben, G; Paschke, R | 1 |
| Altshuler, DM; Hankinson, SE; Hu, FB; Hunter, DJ; Liu, S; Manson, JE; Meigs, JB; Memisoglu, A | 1 |
| Huang, Z; Sui, Y; Weng, J; Xiu, L; Yan, J | 1 |
| Frey, J; Klupa, T; Malecki, MT; Mlynarski, W; Sieradzki, J; Skupien, J; Walus, M | 1 |
| Azuma, J; Igarashi, T; Iwata, E; Motomura, T; Nohnen, S; Ohmoto, M; Tsubakimori, S; Yamamoto, I | 1 |
| Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP | 1 |
| Epe, M; Fehmann, HC; Gross, U | 1 |
| Ani, I; Buchanan, TA; Goico, J; Marroquin, A; Ochoa, C; Shuldiner, AR; Snitker, S; Watanabe, RM; Xiang, AH | 1 |
| Pisabarro, RE; Prendez, D; Sanguinetti, C; Stoll, M | 1 |
| Doney, AS; Fischer, B; Leese, G; Morris, AD; Palmer, CN | 1 |
| Aertgeerts, K; Hilgers, M; Hosfield, DJ; Jennings, A; Skene, RJ; Snell, GP; Wu, Y | 1 |
| Andel, M; Cerná, M; Cimburová, M; Kolostová, K; Kubena, A; Novota, P; Pintérová, D; Romzová, M | 1 |
| Berthold, HK; Faust, M; Giannakidou, E; Gouni-Berthold, I; Kotzka, J; Krone, W; Müller-Wieland, D | 1 |
| Charles, MA; Charpentier, G; Clément, K; Froguel, P; Ghoussaini, M; Lobbens, S; Meyre, D; Tauber, M; Weill, J | 1 |
| Andersen, G; Borch-Johnsen, K; Carstensen, B; Drivsholm, T; Ek, J; Glümer, C; Hansen, SK; Hansen, T; Jørgensen, T; Mouritzen, P; Nielsen, EM; Pedersen, O | 1 |
| Brismar, K; Ding, B; Efendic, S; Gu, HF; Kärvestedt, L; Nordman, S; Ostenson, CG | 1 |
| Abboa-Offei, B; Augeri, DJ; Betebenner, DA; Biller, SA; Cap, M; Chang, SY; Egan, DM; Hamann, LG; Han, SP; Huang, Q; Khanna, A; Kirby, MS; Magnin, DR; Marcinkeviciene, J; Parker, RA; Robertson, JG; Robl, JA; Simpkins, LM; Tao, L; Taunk, P; Tozzo, E; Wang, A; Welzel, GE; Xin, L | 1 |
| Frossard, PM; Haider, SR; Khanum, S; Nazir, A; Saleheen, D | 1 |
| Ciechanowicz, A; Frankow, M; Majkowska, L; Moleda, P; Parczewski, M; Pilarska, K; Safranow, K; Stefański, A | 1 |
| Xie, J; Yu, Y; Zhang, A; Zhang, J; Zhang, M | 1 |
| Adamiec, R; Bednarska-Chabowska, D; Dobosz, T; Gacka, M; Szymaniec, S | 1 |
| Bowden, DW; Brancati, FL; Elbein, SC; Freedman, BI; Kao, WH; Karim, MA; Shuldiner, AR; Wang, X | 1 |
| Chung, JH; Lee, BC; Lee, HJ | 1 |
| Castaldo, I; Cocozza, S; Donnarumma, G; Galasso, R; Giacchetti, M; Lapice, E; Monticelli, A; Pinelli, M; Riccardi, G; Rivellese, AA; Vaccaro, O | 1 |
| Kesäniemi, YA; Ukkola, O | 1 |
| Cannella, C; Corbo, RM; De Stefano, GF; Pacella, A; Pinto, A; Rickards, O; Scacchi, R | 1 |
| Adeli, K; Bahrami, Y; Ghaemi, A; Khatami, S; Khoshbin, E; Larijani, B; Meshkani, R; Mirkhani, F; Molapour, A; Sadeghi, S; Taghikhani, M | 1 |
| Jaakkola, U; Kallio, J; Karvonen, MK; Koulu, M; Pesonen, U; Seppälä, H; Vahlberg, T | 1 |
| Stumvoll, M; Tönjes, A | 1 |
| Aro, A; Groop, L; Lyssenko, V; Salminen, I; Saloranta, C; Virtanen, SM; Ylönen, SK | 1 |
| Al-Hamaq, AO; Al-Rikabi, A; Badii, R; Bener, A; Froguel, P; Ghoussaini, M; Simsek, M; Wareham, NJ; Zirie, M | 1 |
| Altshuler, D; Delahanty, L; Florez, JC; Franks, PW; Hanson, RL; Jablonski, KA; Kahn, SE; Knowler, WC | 1 |
| Hawrami, K; Hitman, GA; McCarthy, MI; Nissinen, A; Pedersen, O; Ramachandran, A; Snehalatha, C; Tuomilehto, J; Tuomilehto-Wolf, E; Viswanathan, M | 1 |
| Akanuma, Y; Hagura, R; Kadowaki, H; Kadowaki, T; Kosaka, K; Otabe, S; Sakura, H; Shimokawa, K; Yazaki, Y | 1 |
| Distler, A; Engeli, S; Ringel, J; Sharma, AM | 1 |
| Chambers, ST; Dellow, WJ; Lever, M; Lunt, H; Robson, RA | 1 |
| Deninger, M; Haist, K; Häring, HU; Koch, M; Maerker, E; Renn, W; Rett, K; Volk, A | 1 |
| Colantuoni, V; Mancini, FP; Riccardi, G; Rivellese, AA; Sabatino, L; Tufano, A; Vaccaro, O | 1 |
| Clausen, JO; Durviaux, SM; Eiberg, H; Ek, J; Hansen, T; Lemaigre, FP; Møller, AM; Pedersen, O; Rousseau, GG; Urhammer, SA | 1 |
| Beamer, BA; Charpentier, G; Clement, K; Froguel, P; Galan, P; Guy-Grand, B; Hercberg, S; Passinge, B; Shuldiner, AR; Vaisse, C; Varroud-Vial, M | 1 |
| Karvonen, MK; Koulu, M; Laakso, M; Mercuri, M; Niskanen, L; Pesonen, U; Rauramaa, R; Töyry, J; Uusitupa, MI; Valve, R | 1 |
| Karvonen, MK; Koulu, M; Laakso, M; Niskanen, L; Pesonen, U; Teräsvirta, M; Uusitupa, MI; Valve, R; Voutilainen-Kaunisto, R | 1 |
| Altshuler, D; Bolk, S; Brewer, C; Daly, M; Gaudet, D; Groop, L; Hirschhorn, JN; Hudson, TJ; Klannemark, M; Lander, ES; Lane, CR; Lindgren, CM; Nemesh, J; Schaffner, SF; Tuomi, T; Vohl, MC | 1 |
| Elbein, SC; Hasstedt, SJ; Ren, QF; Teng, K | 1 |
| Bjørkhaug, L; Horikawa, Y; Molven, A; Njølstad, PR; Søvik, O; Ye, H | 1 |
| Andersen, G; Berglund, L; Borch-Johnsen, K; Carstensen, B; Drivsholm, T; Ek, J; Hansen, L; Hansen, T; Lithell, H; Pedersen, O; Urhammer, SA | 1 |
| Barth, N; Schäffler, A; Schmitz, G; Schölmerich, J; Spiegel, D; Zietz, B | 1 |
| Cai, M; Chen, H; Cheng, L; Fu, M; Fu, Z; Li, J; Li, X; Wu, B | 1 |
| Bendlová, B; Hainer, V; Hill, M; Kunesová, M; Srámková, D; Vcelák, J | 1 |
| Barker, DJ; Eriksson, JG; Forsén, TJ; Laakso, M; Lindi, V; Osmond, C; Uusitupa, M | 1 |
| Bannai, C; Bannai, S; Okuda, Y; Yamashita, K | 1 |
| Fazzi, L; Ricci, F; Ricci, PD | 1 |
9 review(s) available for proline and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Updated Meta-Analysis of Cardiovascular Outcome Trials Evaluating Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Proline; Treatment Outcome | 2021 |
Efficacy and safety of efpeglenatide in adults with obesity and its associated metabolic disturbance: A systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Obesity; Proline; Randomized Controlled Trials as Topic | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Topics: Arginine; Child; Codon, Nonsense; Congenital Hyperinsulinism; Diabetes Mellitus, Type 2; Female; Glucokinase; Glucose Tolerance Test; Glutamic Acid; Humans; Hypoglycemic Agents; Infant, Newborn; Mutation; Proline | 2013 |
Population description and its role in the interpretation of genetic association.
Topics: Alanine; Diabetes Mellitus, Type 2; Gene Frequency; Genetic Predisposition to Disease; Humans; Patient Selection; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Racial Groups; Reproducibility of Results; Validation Studies as Topic; White People | 2010 |
Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
Topics: Alanine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genetic Predisposition to Disease; Genotype; Humans; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; PPAR gamma; Proline | 2012 |
The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
Topics: Adipocytes; Alanine; Amino Acid Substitution; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Humans; Insulin; Insulin Secretion; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
Topics: Alanine; Alleles; Amino Acid Substitution; Diabetes Mellitus, Type 2; Environment; Gene Frequency; Genotype; Humans; Polymorphism, Genetic; PPAR gamma; Proline; Risk Factors | 2007 |
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
Topics: Adult; Age of Onset; Aged; Alanine; Alleles; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Family Health; Fathers; Female; Genotype; Humans; Linkage Disequilibrium; Lipoproteins, HDL; Male; Middle Aged; Models, Genetic; Mothers; Phenotype; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Risk Factors; Transcription Factors | 2000 |
13 trial(s) available for proline and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Proline; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Proline; Treatment Outcome | 2022 |
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Proline; Treatment Outcome | 2020 |
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Proline | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Gastric Emptying; Glucose; Humans; Liraglutide; Proline | 2021 |
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide-1 Receptor; Heart Disease Risk Factors; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Kidney Diseases; Male; Middle Aged; Proline | 2021 |
Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Topics: Aged; Alanine; Amino Acid Substitution; Body Composition; Diabetes Mellitus, Type 2; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Fish Oils; Humans; Middle Aged; Placebos; Polymorphism, Genetic; PPAR gamma; Proline | 2015 |
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
Topics: Adult; Aged; Alanine; Albuminuria; Alleles; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Hypertension; Incidence; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Prospective Studies; Research Design; Risk Factors | 2009 |
Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
Topics: Alanine; Amino Acid Substitution; Blood Glucose; Body Constitution; Body Mass Index; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Finland; Genotype; Glucose Intolerance; Humans; Incidence; Insulin; Male; Middle Aged; Mutation, Missense; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Regression Analysis; Transcription Factors | 2002 |
Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes.
Topics: Aged; Alanine; Blood Glucose; Diabetes Mellitus, Type 2; Female; Genotype; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Proline; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Treatment Outcome | 2003 |
Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabe
Topics: Alanine; Amino Acid Substitution; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; DNA Primers; Female; Genetic Variation; Hispanic or Latino; Humans; Hypoglycemic Agents; Insulin; Polymerase Chain Reaction; PPAR gamma; Proline; Thiazolidinediones; Troglitazone | 2004 |
The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Topics: Adult; Alanine; Amino Acid Substitution; Body Composition; Chromans; Diabetes Mellitus, Type 2; Dietary Fats; Eating; Female; Gene Frequency; Genotype; Humans; Hypoglycemic Agents; Life Style; Male; Metformin; Middle Aged; Obesity; Placebos; PPAR gamma; Proline; Thiazolidinediones; Troglitazone | 2007 |
88 other study(ies) available for proline and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.
Topics: Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney; Proline | 2021 |
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.
Topics: Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney; Proline | 2021 |
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.
Topics: Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney; Proline | 2021 |
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Reply.
Topics: Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney; Proline | 2021 |
Serum untargeted metabolomics analysis of the mechanisms of evodiamine on type 2 diabetes mellitus model rats.
Topics: Amino Sugars; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glutathione; Metabolomics; Nucleotides; Proline; Quinazolines; Rats; Streptozocin; Tryptophan | 2022 |
Stachydrine alleviates lipid-induced skeletal muscle insulin resistance via AMPK/HO-1-mediated suppression of inflammation and endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Endoplasmic Reticulum Stress; Glucose; Inflammation; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Palmitates; Proline; RNA; Tumor Necrosis Factor-alpha | 2022 |
Letter by Groothof et al Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial".
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Proline; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Amino acids, microbiota-related metabolites, and the risk of incident diabetes among normoglycemic Chinese adults: Findings from the 4C study.
Topics: 2-Aminoadipic Acid; Adult; Alanine; Amino Acids; Asparagine; Diabetes Mellitus, Type 2; Glutamic Acid; Histidine; Homoserine; Humans; Lipids; Methionine; Microbiota; Proline; Uric Acid | 2022 |
A glycogen storage disease type 1a patient with type 2 diabetes.
Topics: Adenoma; Adult; Diabetes Mellitus, Type 2; Electrolytes; Female; Glucose; Glucose-6-Phosphatase; Glycogen Storage Disease Type I; Humans; Insulins; Leucine; Proline; Starch | 2022 |
Metabolomics analysis of stool in rats with type 2 diabetes mellitus after single-anastomosis duodenal-ileal bypass with sleeve gastrectomy.
Topics: Alanine; Amino Acids, Aromatic; Amino Acids, Branched-Chain; Anastomosis, Surgical; Animals; Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Gastrectomy; Glutamates; Glycated Hemoglobin; Ileum; Isobutyrates; Lithocholic Acid; Obesity, Morbid; Phenylalanine; Phospholipids; Proline; Rats; Streptozocin; Valine | 2022 |
Understanding the mechanism of amylin aggregation: From identifying crucial segments to tracing dominant sequential events to modeling potential aggregation suppressors.
Topics: Amyloid; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Proline; Thermodynamics | 2023 |
Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Type 2; Gluconeogenesis; Glucose; Hepatocytes; Humans; Hydroxylation; Liver; Mice; Mice, Inbred C57BL; Proline; Prolyl Hydroxylases | 2023 |
Enhancing the Physiochemical Properties of Puerarin via L-Proline Co-Crystallization: Synthesis, Characterization, and Dissolution Studies of Two Phases of Pharmaceutical Co-Crystals.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Diabetes Mellitus, Type 2; HEK293 Cells; Humans; Isoflavones; Medicine, Chinese Traditional; Mice; Powders; Proline; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2021 |
Associations between serum amino acids and incident type 2 diabetes in Chinese rural adults.
Topics: Adult; Biomarkers; Body Mass Index; China; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Obesity; Proline; Prospective Studies; Risk Assessment; Risk Factors; Rural Health | 2021 |
Potential cardiorenal benefits of efpeglenatide in diabetes.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Proline | 2021 |
Be positive: optimizing pramlintide from microcanonical analysis of amylin isoforms.
Topics: Amyloid; Animals; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Molecular Dynamics Simulation; Proline; Protein Isoforms; Rats; Swine; Thermodynamics | 2017 |
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.
Topics: ADAM Proteins; ADAMTS13 Protein; Aged; Alanine; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Female; Genotype; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Single Nucleotide; Predictive Value of Tests; Proline; Proteolysis; Risk Assessment; Risk Factors; von Willebrand Factor | 2013 |
The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population.
Topics: Adult; Alanine; Amino Acid Substitution; Asian People; Blood Glucose; Body Mass Index; China; Diabetes Mellitus, Type 2; Fasting; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Insulin; Male; Middle Aged; Obesity; Odds Ratio; Polymorphism, Genetic; PPAR gamma; Proline | 2013 |
Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
Topics: Aged; Aged, 80 and over; Alanine; Amino Acid Substitution; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; PPAR gamma; Proline | 2014 |
Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.
Topics: Adult; Alanine; Amino Acid Substitution; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Humans; Insulin Resistance; Longitudinal Studies; Male; Mexican Americans; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Young Adult | 2015 |
Impact of the hypoxia inducible factor-1α (HIF-1α) pro582ser polymorphism and its gene expression on diabetic foot ulcers.
Topics: Adult; Aged; Amino Acid Substitution; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Gene Frequency; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Proline; Serine | 2015 |
Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS.
Topics: Amino Acids, Branched-Chain; Asian People; Blood Glucose; Case-Control Studies; Chromatography, Liquid; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Furans; Gas Chromatography-Mass Spectrometry; Glycated Hemoglobin; Glycerol; Humans; Linoleic Acid; Lysophospholipids; Metabolomics; Oleic Acid; Proline; Propionates; Urea | 2016 |
Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population.
Topics: Adult; Alanine; Asian People; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Humans; India; Male; Polymorphism, Genetic; PPAR gamma; Proline | 2017 |
The metabolites in peripheral blood mononuclear cells showed greater differences between patients with impaired fasting glucose or type 2 diabetes and healthy controls than those in plasma.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Glucose Metabolism Disorders; Humans; Inflammation Mediators; Leucine; Leukocytes, Mononuclear; Lysophosphatidylcholines; Male; Metabolomics; Middle Aged; Proline; Valine | 2017 |
Synthesis and structure-activity relationships of potent 1-(2-substituted-aminoacetyl)-4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
Topics: Animals; Crystallography, X-Ray; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Mice; Proline; Structure-Activity Relationship; Valine | 2008 |
[Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes].
Topics: Alanine; Amino Acid Substitution; Asian People; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genotype; Haplotypes; Humans; Male; Middle Aged; Obesity; Polymorphism, Genetic; PPAR gamma; Proline; Triglycerides | 2008 |
Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.
Topics: Animals; Aorta, Abdominal; Apoptosis; Carotid Artery Injuries; Cell Cycle; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA Replication; Dose-Response Relationship, Drug; Hyperplasia; Male; Metabolic Syndrome; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Proline; Rats; Rats, Zucker; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine; Triazenes; Tyrosine | 2008 |
Breast-feeding modifies the association of PPARgamma2 polymorphism Pro12Ala with growth in early life: the Generation R Study.
Topics: Alanine; Amino Acid Substitution; Body Weight; Breast Feeding; Child; Diabetes Mellitus, Type 2; Female; Fetal Development; Genotype; Growth; Heterozygote; Humans; Infant; Infant, Newborn; Polymorphism, Genetic; PPAR gamma; Pregnancy; Pregnancy Trimester, Second; Proline | 2009 |
The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
Topics: Adult; Alanine; Diabetes Mellitus, Type 2; Female; Humans; Hyperinsulinism; Male; Polymorphism, Genetic; PPAR gamma; Proline | 2009 |
Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
Topics: Alanine; Asian People; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Iran; Logistic Models; Male; Obesity; Odds Ratio; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Risk Assessment; Risk Factors | 2009 |
PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
Topics: Adolescent; Alanine; Amino Acid Substitution; Child; Cohort Studies; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Glucose; Glucose Metabolism Disorders; Glucose Tolerance Test; Homeostasis; Humans; Male; Obesity; Polymorphism, Single Nucleotide; PPAR gamma; Proline | 2011 |
Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients.
Topics: Aged; Analysis of Variance; Brachial Artery; Carotid Artery Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Finland; Flow Cytometry; Genotype; Humans; Inflammation; Interferon-gamma; Leukocytes; Linear Models; Male; Middle Aged; Neuropeptide Y; Phenotype; Proline; Risk Assessment; Risk Factors; Ultrasonography; Vasodilation | 2011 |
MODY type 2 P59S GCK mutant: founder effect in South of Italy.
Topics: Amino Acid Substitution; Codon, Nonsense; Diabetes Mellitus, Type 2; Female; Founder Effect; Germinal Center Kinases; Humans; Italy; Male; Mutation, Missense; Pedigree; Proline; Protein Serine-Threonine Kinases | 2013 |
Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population.
Topics: Adult; Alanine; Amino Acid Substitution; Asian People; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Female; Genetic Association Studies; Hong Kong; Humans; Incidence; Male; Middle Aged; Polymorphism, Single Nucleotide; PPAR gamma; Proline | 2012 |
4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
Topics: Boronic Acids; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Inhibitory Concentration 50; Proline | 2012 |
Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Topics: Alanine; Amino Acid Substitution; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; DNA-Binding Proteins; Female; Genotype; Germany; Humans; Kidney Failure, Chronic; Male; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors; White People | 2002 |
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus.
Topics: Aged; Alanine; Alleles; Antigens, CD; Body Mass Index; Cytokines; Diabetes Mellitus, Type 2; Female; Gene Frequency; Heterozygote; Humans; Leptin; Linear Models; Male; Middle Aged; Mutation; Obesity; Proline; Receptors, Cytoplasmic and Nuclear; Receptors, Leptin; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Sex Characteristics; Transcription Factors | 2002 |
Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.
Topics: Adult; Aged; Animals; Antioxidants; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Gerbillinae; Glucose; Humans; Hyperglycemia; Interleukin-1; Islets of Langerhans; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Proline; Receptors, Interleukin-1; Thiocarbamates | 2002 |
Cellular munc18c levels can modulate glucose transport rate and GLUT4 translocation in 3T3L1 cells.
Topics: 3T3 Cells; Adipocytes; Animals; Antibodies; Biological Transport, Active; Diabetes Mellitus, Type 2; Gene Expression; Glucose; Glucose Transporter Type 4; Insulin; Kinetics; Membrane Proteins; Mice; Microinjections; Monosaccharide Transport Proteins; Munc18 Proteins; Muscle Proteins; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Phosphorylation; Proline; Proteins; Qa-SNARE Proteins; Recombinant Proteins; Syntaxin 1; Vesicular Transport Proteins | 2002 |
Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.
Topics: Adult; Alanine; Amino Acid Substitution; Body Mass Index; Body Weight; Cytosine; Diabetes Mellitus, Type 2; Exercise; Female; Genetic Carrier Screening; Genetic Testing; Genetic Variation; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Regression Analysis; Thymine; Transcription Factors | 2002 |
Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
Topics: Alanine; Antibodies, Anticardiolipin; Autoantibodies; Diabetes Mellitus, Type 2; Female; Genotype; Humans; Lipoproteins, LDL; Male; Middle Aged; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Reference Values; Transcription Factors | 2003 |
Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes.
Topics: Alanine; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; Incidence; Middle Aged; Polymorphism, Genetic; Proline; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Risk Factors; Transcription Factors | 2003 |
Missense mutation of Pro387Leu in protein tyrosine phosphatase-1B (PTP-1B) is not associated with type 2 diabetes in a Chinese Han population.
Topics: Asian People; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Humans; Leucine; Mutation, Missense; Proline; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases | 2003 |
The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
Topics: Age of Onset; Alanine; Amino Acid Substitution; Body Mass Index; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genotype; Glycated Hemoglobin; Humans; Middle Aged; Poland; Polymorphism, Restriction Fragment Length; Proline; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Reference Values; Transcription Factors; White People | 2003 |
The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.
Topics: Adult; Aged; Alanine; Arteriosclerosis; Base Sequence; Body Mass Index; Carotid Arteries; Diabetes Mellitus, Type 2; DNA; DNA Primers; Humans; Japan; Middle Aged; Polymorphism, Single Nucleotide; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tunica Intima; Tunica Media | 2003 |
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Topics: Adenosine Deaminase; Amino Acid Substitution; Animals; Binding, Competitive; Blood Glucose; Cell Line, Tumor; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Peptide Fragments; Phenylalanine; Proline; Protein Precursors; Rats; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization; Transformation, Genetic; Tyrosine | 2003 |
A new mutation in the hepatocyte nuclear factor-1-alpha gene (P224S) in a newly discovered German family with maturity-onset diabetes of the young 3 (MODY 3). Family members carry additionally the homozygous I27L amino acid polymorphism in the HNF1 alpha
Topics: Adolescent; Aged; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Exons; Female; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Homozygote; Humans; Insulin Resistance; Isoleucine; Leucine; Male; Mutation; Nuclear Proteins; Proline; Serine; Transcription Factors | 2004 |
High incidence of type 2 diabetes in peroxisome proliferator-activated receptor gamma2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids.
Topics: Adult; Alanine; Amino Acid Substitution; Diabetes Mellitus, Type 2; Dietary Fats; Energy Intake; Female; Genetic Carrier Screening; Humans; Male; Middle Aged; Pilot Projects; Point Mutation; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Risk Factors; Trans Fatty Acids; Uruguay | 2004 |
Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.
Topics: Age Factors; Alanine; Alleles; Amino Acid Substitution; Cardiovascular Diseases; Cohort Studies; Cytosine; Diabetes Mellitus, Type 2; Female; Genetic Testing; Genetic Variation; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; PPAR gamma; Proline; Risk Factors; Sex Factors; Smoking; Thymine | 2004 |
Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Amino Acid Motifs; Binding Sites; Cloning, Molecular; Cortisone; Crystallography, X-Ray; Cysteine; Diabetes Mellitus, Type 2; Dimerization; Disulfides; Endoplasmic Reticulum; Enzyme Inhibitors; Escherichia coli; Glucocorticoids; Humans; Hydrocortisone; Kinetics; Mass Spectrometry; Models, Molecular; Mutagenesis; Obesity; Oxygen; Point Mutation; Proline; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins | 2005 |
The frequency of alleles of the Pro12Ala polymorphism in PPARgamma2 is different between healthy controls and patients with type 2 diabetes.
Topics: Adult; Aged; Alanine; Alleles; Case-Control Studies; Czech Republic; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Lipids; Male; Middle Aged; Polymorphism, Restriction Fragment Length; PPAR gamma; Proline | 2004 |
Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Analysis of Variance; Blood Pressure; Chi-Square Distribution; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Gene Frequency; Heterozygote; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; PPAR gamma; Proline; Retrospective Studies | 2005 |
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
Topics: Adolescent; Adult; Alanine; Amino Acid Substitution; Case-Control Studies; Child; Diabetes Mellitus, Type 2; Female; France; Gene Frequency; Genetic Predisposition to Disease; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Phenotype; Polymorphism, Single Nucleotide; PPAR gamma; Proline; White People | 2005 |
Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes.
Topics: Adult; Alanine; Amino Acid Substitution; Body Mass Index; Cohort Studies; Diabetes Mellitus, Type 2; Female; Genetic Variation; Glutamine; Humans; Lysine; Male; Middle Aged; Mutation, Missense; Potassium Channels, Inwardly Rectifying; PPAR gamma; Proline; Risk Factors | 2005 |
Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
Topics: Adult; Alleles; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucose Intolerance; Heterozygote; Humans; Insulin; Leucine; Male; Middle Aged; Neuropeptide Y; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Sex Characteristics; Sweden | 2005 |
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Topics: Adamantane; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl Peptidase 4; Glucose Tolerance Test; Glycine; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Mice; Mice, Obese; Microsomes, Liver; Nitriles; Proline; Protease Inhibitors; Rats; Rats, Zucker; Stereoisomerism; Structure-Activity Relationship | 2005 |
R1615P: a novel mutation in ABCA1 associated with low levels of HDL and type II diabetes mellitus.
Topics: Adult; Alleles; Amino Acid Sequence; Amino Acid Substitution; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cholesterol, HDL; Conserved Sequence; Diabetes Mellitus, Type 2; Exons; Heterozygote; Humans; Male; Molecular Sequence Data; Proline; Sequence Homology, Amino Acid | 2006 |
Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Topics: Alanine; Alleles; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Polymorphism, Genetic; PPAR gamma; Proline; Time Factors | 2006 |
The influence of the Pro12Ala mutation of PPARgamma2 receptor gene on beta-cells restoration and insulin resistance in type 2 diabetes with hypertension.
Topics: Alanine; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Hypertension; Insulin Resistance; Insulin-Secreting Cells; Mutation; PPAR gamma; Proline | 2005 |
[Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Endothelium; Female; Genetic Predisposition to Disease; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; PPAR gamma; Proline; Transcription Factors | 2005 |
Role of a proline insertion in the insulin promoter factor 1 (IPF1) gene in African Americans with type 2 diabetes.
Topics: Amino Acid Sequence; Black or African American; Case-Control Studies; Diabetes Mellitus, Type 2; Homeodomain Proteins; Humans; Proline; Risk Factors; Trans-Activators | 2006 |
Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
Topics: Aged; Alanine; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Peroxisome Proliferator-Activated Receptors; Polymorphism, Genetic; Proline; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke | 2006 |
Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diet, Diabetic; Energy Metabolism; Feeding Behavior; Female; Genetic Carrier Screening; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Weight Gain | 2007 |
Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
Topics: Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genotype; Ghrelin; Humans; Hypertension; Insulin; Insulin Secretion; Leucine; Male; Middle Aged; Neuropeptide Y; Peptide Hormones; Polymorphism, Genetic; Proline; Protein Precursors; Risk Factors | 2007 |
An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Benin; Climate; Diabetes Mellitus, Type 2; Dietary Fats; Ecuador; Environment; Ethiopia; Feeding Behavior; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Italy; Male; Middle Aged; Polymorphism, Genetic; PPAR gamma; Prevalence; Proline | 2007 |
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
Topics: Alanine; Base Sequence; Diabetes Mellitus, Type 2; DNA Primers; Genetic Predisposition to Disease; Humans; Insulin Resistance; Iran; Polymorphism, Genetic; PPAR gamma; Proline | 2007 |
Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
Topics: Aged; Amino Acid Substitution; Blood Glucose; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Humans; Hydrocortisone; Leptin; Leucine; Male; Middle Aged; Neuropeptide Y; Polymorphism, Genetic; Proline; Protein Precursors | 2007 |
The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Topics: Alanine; Alleles; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet Records; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Female; Genotype; Heterozygote; Homozygote; Humans; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Polymorphism, Genetic; PPAR gamma; Proline; Sex Factors | 2008 |
Lack of association between the Pro12Ala polymorphism of the PPAR-gamma 2 gene and type 2 diabetes mellitus in the Qatari consanguineous population.
Topics: Adult; Alanine; Amino Acid Substitution; Body Mass Index; Consanguinity; Diabetes Mellitus, Type 2; DNA; Female; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Qatar; Reference Values | 2008 |
Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease.
Topics: Adult; Aged; Alanine; Arginine; Base Sequence; Case-Control Studies; Codon; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; DNA Primers; Female; Finland; Genotype; Glycine; Humans; India; Insulin Receptor Substrate Proteins; Male; Middle Aged; Molecular Sequence Data; Pedigree; Phosphoproteins; Point Mutation; Polymerase Chain Reaction; Proline; Reference Values; Restriction Mapping; Risk Factors | 1995 |
Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus.
Topics: Alanine; Alleles; Amino Acid Sequence; Arginine; Base Sequence; Blood Glucose; Diabetes Mellitus, Type 2; DNA Primers; Genotype; Glycated Hemoglobin; Glycine; Glycogen Synthase; Humans; Insulin; Insulin Receptor Substrate Proteins; Japan; Middle Aged; Molecular Sequence Data; Phosphoproteins; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Repetitive Sequences, Nucleic Acid | 1994 |
Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
Topics: Adult; Alanine; Amino Acid Substitution; Cholesterol; Codon; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Gene Frequency; Genetic Variation; Humans; Hyperlipidemias; Male; Middle Aged; Mutation, Missense; Nuclear Proteins; Obesity; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Triglycerides | 1999 |
Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia.
Topics: Adult; Aged; Aged, 80 and over; Alkaloids; Betaine; Biomarkers; Carnitine; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Proline | 1999 |
The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
Topics: Adult; Alanine; Amino Acid Substitution; Codon; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Mutation; Obesity; Polymorphism, Genetic; Proline; Quantitative Trait, Heritable; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 1999 |
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
Topics: Adipose Tissue; Adult; Aged; Alanine; Case-Control Studies; Diabetes Mellitus, Type 2; Humans; Male; Middle Aged; Odds Ratio; Point Mutation; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 1999 |
Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.
Topics: Adult; Alanine; Alleles; Amino Acid Substitution; Chromosome Mapping; Chromosomes, Human, Pair 15; Cloning, Molecular; Diabetes Mellitus, Type 2; Exons; Female; Gene Frequency; Genetic Variation; Hepatocyte Nuclear Factor 6; Homeodomain Proteins; Humans; Insulin; Insulin Secretion; Introns; Male; Middle Aged; Mutation, Missense; Polymorphism, Single-Stranded Conformational; Proline; Registries; Trans-Activators; White People | 1999 |
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
Topics: Adult; Aged; Alanine; Diabetes Mellitus, Type 2; Female; Genotype; Glutamine; Humans; Male; Middle Aged; Mutation; Obesity, Morbid; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
Topics: Aged; Amino Acid Substitution; Arteriosclerosis; Autonomic Nervous System; Blood Pressure; Carotid Stenosis; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Genotype; Heart Rate; Humans; Leucine; Male; Neuropeptide Y; Polymorphism, Genetic; Proline; Risk Factors | 2000 |
Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
Topics: Aged; Amino Acid Substitution; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Finland; Follow-Up Studies; Glycated Hemoglobin; Humans; Leucine; Male; Middle Aged; Neuropeptide Y; Polymorphism, Genetic; Proline; Time Factors | 2000 |
Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds.
Topics: Alanine; Amino Acid Substitution; Blood Glucose; Blood Pressure; Body Mass Index; Chromosomes, Human, Pair 3; Diabetes Mellitus; Diabetes Mellitus, Type 2; Family; Gene Frequency; Genetic Variation; Glucose Tolerance Test; Humans; Leptin; Microbodies; Middle Aged; Nuclear Family; Obesity; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors; White People | 2001 |
MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X).
Topics: Diabetes Mellitus, Type 2; DNA; DNA Mutational Analysis; DNA-Binding Proteins; Female; Glutamine; HeLa Cells; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Hepatocytes; Humans; Immunohistochemistry; Leucine; Male; Mutagenesis, Site-Directed; Nuclear Proteins; Pedigree; Proline; Transcription Factors; Transcriptional Activation | 2000 |
Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
Topics: Aged; Alanine; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin Resistance; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Receptors, Cytoplasmic and Nuclear; Sweden; Transcription Factors | 2001 |
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
Topics: Aged; Alanine; Alleles; Cholesterol; Cholesterol, LDL; Cohort Studies; Diabetes Mellitus, Type 2; Female; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Logistic Models; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Proline; Receptors, Cytoplasmic and Nuclear; Sex Characteristics; Transcription Factors | 2002 |
[Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Topics: Adult; Alanine; Alleles; Amino Acid Substitution; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genotype; Humans; Insulin; Male; Middle Aged; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Triglycerides | 2002 |
Is a Pro12Ala polymorphism of the PPARgamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population?
Topics: Adult; Alanine; Case-Control Studies; Czechoslovakia; Diabetes Mellitus, Type 2; Female; Genetics, Population; Genotype; Humans; Male; Middle Aged; Obesity; Phenotype; Polymorphism, Genetic; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.
Topics: Alanine; Amino Acid Substitution; Birth Weight; Diabetes Mellitus, Type 2; Female; Humans; Infant, Newborn; Insulin; Male; Middle Aged; Polymorphism, Single Nucleotide; Proline; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Effect of insulin on the proline transport activity in cultured fibroblasts from patients with Werner syndrome.
Topics: Adolescent; Adult; Biological Transport; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Fibroblasts; Humans; Male; Middle Aged; Proline; Reference Values; Skin; Werner Syndrome | 1992 |
[Captopril in the control of essential arterial hypertension in diabetic subjects].
Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Proline | 1985 |